Percutaneously deliverable heart valve

Abstract

This invention discloses a percutaneously deliverable heart valve and delivery means thereof, wherein the percutaneously deliverable heart valve is a foldable heart valve prosthesis to replace a diseased valve of a patient comprising: a support structure with a diameter, wherein the support structure is foldable to a smaller diameter, the support structure comprising a plurality of crossbar frames, wherein each crossbar frame has a plurality of crossbars connected at an end of each crossbar; a flexible tissue heart valve with a plurality of valvular leaflets attached to the support structure; and a plurality of slidable ring connectors, wherein at least a slidable ring connector encircles a first crossbar from a first crossbar frame and a second crossbar from a second crossbar frame configured to coupling the first and the second crossbars.

Description

RELATED APPLICATION [0001] The present application is a continuation of U.S. patent application Ser. No. 10 / 241,718, the entirety of which is hereby incorporated by reference.FIELD OF THE INVENTION [0002] The present invention relates to a prosthetic valve for implantation in a body channel, more particularly, to a percutaneously implantable prosthetic heart valve suitable for replacement of a defect or diseased human heart valve. BACKGROUND OF THE INVENTION [0003] Replacement heart valves or heart valve prostheses have been fabricated or manufactured for the last forty years. Such devices have been assembled from a variety of materials. Specifically the materials have been of the biologic or artificial nature, generally leading to two distinct categories of the prostheses as biological or mechanical replacement heart valves. [0004] The prosthetic heart valves are fabricated to replace the natural heart valves that, because of disease, congenital malformations, aging or trauma have ...

AI Technical Summary

Benefits of technology

"The present invention provides a foldable heart valve prosthesis that can be used to replace a diseased valve in a patient. The prosthesis includes a support structure with a plurality of close-loop crossbar frames and a flexible tissue heart valve with a plurality of valvular leaflets attached to the support structure. The prosthesis also includes a plurality of slidable ring connectors that can be used to couple the crossbars. The invention also provides a method for minimally invasively delivering the foldable heart valve prosthesis into a patient. The technical effects of the invention include a smaller size of the prosthesis for easier delivery, flexibility of the tissue heart valve, and the ability to be implanted in a minimally invasive way."

Problems solved by technology

Similarly, they close under the pressure exerted on the same leaflet elements when blood flow is retrograde, thus impeding return of blood flow to the chamber it has just left.

When disease conditions affect the structure of the materials of the components of the valve apparatus, the valve itself will decay, degenerate or disrupt and require repair or replacement to restore proper function necessary for the continuation of life.

Those valves used in the aortic position cannot alone replace the mitral valve apparatus without anatomical and functional compromise.

In such aortic diseases, patients can have syncope, chest pain, and difficulty in breathing.

The evolution of such a disease is disastrous when symptoms of cardiac failure appear and many patients die in the year following the first symptoms of the disease.

Unfortunately, the result is sub-optimal with a high restenosis rate.

Until recently, the implantation of a valve prosthesis for the treatment of aortic stenosis is considered unrealistic to perform since it is deemed difficult to superimpose another implantable valve on the distorted stenosed native valve without excising the latter.

However, the support structure is a generally fixed expandable-collapsible structure with little flexibility of modifying configuration at the collapsed shape for easy delivery percutaneously.

This type of design is inherently fragile, and such structures are not strong enough to be used in the case of aortic stenosis because of the strong recoil that will distort this weak structure and because they would not be able to resist the balloon inflation performed to position the implantable valve.

However, the expandable frame is a generally fixed expandable-collapsible structure with little flexibility of modifying configuration or minimizing the profile at the collapsed stage for easy delivery percutaneously.

In some aspects, this intravascular procedure is not only dangerous and tedious because of the long tortuous route, but also of limited use because of the catheter size suitable for insertion intravascularly.

However, the presence of the support structure consisting of a stent and sewing ring prevents the tissue valve from being anatomically accurate in comparison to a normal heart valve.

Images